FDA Approval Summary: Sonidegib-Response.

Stacy S Shord,Denise Casey,Hong Zhao,Suzanne Demko,Patricia Keegan,Richard Pazdur

CLINICAL CANCER RESEARCH（2017）

引用 4|浏览22

暂无评分

摘要

Race and ethnicity are important considerations during drug development, with differential effects in drug exposure, efficacy, and safety across racial groups observed for some drugs. Gyawali and Ando ([1][1]) suggest that the recommended dose of 200 mg once daily for sonidegib may not be

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要